Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

Potential of phenothiazines to synergistically block calmodulin and reactivate PP2A in cancer cells

View ORCID ProfileSunday Okutachi, View ORCID ProfileGanesh babu Manoharan, View ORCID ProfileDaniel Abankwa
doi: https://doi.org/10.1101/2021.06.16.448716
Sunday Okutachi
Cancer Cell Biology and Drug Discovery Group, Department of Life Sciences and Medicine, University of Luxembourg, 4362 Esch-sur-Alzette, Luxembourg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sunday Okutachi
Ganesh babu Manoharan
Cancer Cell Biology and Drug Discovery Group, Department of Life Sciences and Medicine, University of Luxembourg, 4362 Esch-sur-Alzette, Luxembourg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ganesh babu Manoharan
Daniel Abankwa
Cancer Cell Biology and Drug Discovery Group, Department of Life Sciences and Medicine, University of Luxembourg, 4362 Esch-sur-Alzette, Luxembourg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Daniel Abankwa
  • For correspondence: daniel.abankwa@uni.lu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Preview PDF
Loading

Abstract

Phenothiazines (PTZ) are well known as inhibitors of monoamine neurotransmitter receptors, notably dopamine receptors. Because of this activity they are used for decades as antipsychotic drugs. In addition, significant anti-cancer properties have been ascribed to them. Several attempts for their repurposing were made, however, their incompletely understood polypharmacology is challenging.

Here we examined the potential of PTZ to synergistically act on two cancer associated targets, calmodulin (CaM) and the tumor suppressor protein phosphatase 2A (PP2A). Both proteins are known to modulate the Ras-MAPK pathway activity. Consistently, combinations of a CaM inhibitor and a PP2A activator synergistically inhibited cancer cells with KRAS or BRAF mutations. We identified the covalently reactive PTZ derivative fluphenazine mustard as an inhibitor of Ras driven proliferation and Ras membrane organization. We confirmed its anti-CaM activity in vitro and through a cellular CaM target engagement bioluminescence resonance energy transfer (BRET) assay. Our results suggest that improved PTZ derivatives retaining their synergistic CaM inhibitory and PP2A activating properties, but without neurological side-effects, may be interesting to pursue further as anti-cancer agents.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted June 17, 2021.
Download PDF
Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Potential of phenothiazines to synergistically block calmodulin and reactivate PP2A in cancer cells
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Potential of phenothiazines to synergistically block calmodulin and reactivate PP2A in cancer cells
Sunday Okutachi, Ganesh babu Manoharan, Daniel Abankwa
bioRxiv 2021.06.16.448716; doi: https://doi.org/10.1101/2021.06.16.448716
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Potential of phenothiazines to synergistically block calmodulin and reactivate PP2A in cancer cells
Sunday Okutachi, Ganesh babu Manoharan, Daniel Abankwa
bioRxiv 2021.06.16.448716; doi: https://doi.org/10.1101/2021.06.16.448716

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Biochemistry
Subject Areas
All Articles
  • Animal Behavior and Cognition (3573)
  • Biochemistry (7517)
  • Bioengineering (5478)
  • Bioinformatics (20671)
  • Biophysics (10254)
  • Cancer Biology (7927)
  • Cell Biology (11566)
  • Clinical Trials (138)
  • Developmental Biology (6563)
  • Ecology (10130)
  • Epidemiology (2065)
  • Evolutionary Biology (13532)
  • Genetics (9496)
  • Genomics (12788)
  • Immunology (7869)
  • Microbiology (19443)
  • Molecular Biology (7611)
  • Neuroscience (41862)
  • Paleontology (306)
  • Pathology (1252)
  • Pharmacology and Toxicology (2179)
  • Physiology (3249)
  • Plant Biology (7005)
  • Scientific Communication and Education (1291)
  • Synthetic Biology (1941)
  • Systems Biology (5405)
  • Zoology (1107)